Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Granata Bio

Explore full profile

Innovative solutions in reproductive health, enhancing drug discovery and clinical trials through strategic partnerships

Boston, United StatesFounded 2018Biotech & Life Sciences
Valuation $50–100M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Granata Bio and the history behind them.

About Granata Bio

To find and grow fertility solutions for patients

Source: Dealroom company data

At a glance

Status
Operational
Founded
2018
Headquarters
Boston, United States
Employees
18
Open positions
2
Dealroom signal
88.6/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b
Investment activity
1 company, latest Apr 2025
Capital deployed
—
Preferred round
ACQUISITION
Links
WebsiteLinkedInX

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jan 2025 $15M $60M Amboy Street Ventures (ASV) · Gedeon Richter · CooperSurgical ↗
SERIES A✓Equity / VC Jan 2024 $14M $56M Amboy Street Ventures (ASV) · Gedeon Richter · CooperSurgical · GV ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Granata Bio website traffic

Latest recorded traffic for Granata Bio is 1.9K monthly website visits, down 17.4% over the last three months. Granata Bio's team grew 20% over the past year.

Latest monthly visits1.9K 3-month web change-17.4% 1-year team growth+20%
Monthly website visitsJun 2022–Jul 2026
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
Associate Product Development Manager289, Saint George Street, Millbrook, Duxbury, Plymouth County, Massachusetts, 02332, United States · Business Development · Sep 6, 2026 Regulatory CMC Manager289, Saint George Street, Millbrook, Duxbury, Plymouth County, Massachusetts, 02332, United States · Legal · Jul 28, 2026 Associate Director, Commercial Operations289, Saint George Street, Millbrook, Duxbury, Plymouth County, Massachusetts, 02332, United States · Sales · Jul 5, 2026
3 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
New American TherapeuticsA privately held, specialty pharmaceutical company that acquires, markets and develops products in select therapeutic areas Parsippany-Troy Hills, United States Operational — $53M —
Steel TherapeuticsFocused on increasing access to life-changing therapies with a track record of efficacy from compounding pharmacies Iowa City, United States Operational
CellmAbsCellmabs is focused on researching and developing innovative biopharmaceuticals for the treatment of cancer Óbidos, Portugal Acquired
ImmuneOnco BiopharmaDedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells Huangpu, China Operational
AutolusProgrammed T-cell immunotherapies for cancer and autoimmune diseases London, United Kingdom Operational
UppertonPharmaceutical CDMO for oral and nasal dosage forms Nottingham, United Kingdom Operational
Caris Life SciencesA profiling platform that identifies novel molecular targets to inform and enhance drug development and advanced diagnostics Irving, United States Operational
Leap TherapeuticsA biopharmaceutical company in the clinical stage, acquiring and advancing innovative therapeutics at the forefront of cancer research Cambridge, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Oviva TherapeuticsNew York City, United StatesA movement to improve women's experience of aging through biomedical research, development and advocacy $46Mvaluation
1 profiles shownExplore the complete relationship graph →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

Other known investors1 additional known investor

  • What If Ventures

Talent

Book a demo to see the people
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States64.3%
🇨🇭 Switzerland14.3%
🇧🇷 Brazil7.1%
🇬🇧 United Kingdom7.1%
🇩🇪 Germany7.1%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Granata Bio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Granata Bio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.